SynAgile's Unattributed - II Round

SynAgile raised a round of funding on January 26, 2017.

SynAgile is developing DopaFuse, designed to be the first patient-friendly, noninvasive therapy for continuous delivery of L-DOPA and carbidopa. The medication is delivered from a small, comfortable d…

Articles about SynAgile's Unattributed - II Round: